Hyperpolarizing factors

Biochemical Pharmacology

Volumn 54, Issue 10, 1997, Pages 1059-1070

  Quilley, John ^a   Fulton, David ^a   McGiff, John C ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Arachidonic acid; Bradykinin; Cytochrome P450 AA; Endothelium; Endothelium derived hyperpolarizing factor; Nitric oxide

Indexed keywords

ARACHIDONIC ACID; BRADYKININ; CYTOCHROME P450; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; NITRIC OXIDE;

ARTERY MUSCLE; CORONARY ARTERY DILATATION; ENDOTHELIUM; MICROVASCULATURE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; VASCULAR ENDOTHELIUM; VASODILATATION;

EID: 0030669283     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(97)00039-7     Document Type: Article

References (134)

1. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
2. Vane JR, Anggard EE, Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med. 323:1990;27-36.
3. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:1987;524-526.
4. Ignarro LJ, Buga GM, Wood KS, Byrns RE, Chaudhuri G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA. 84:1987;9265-9269.
5. Rees DD, Palmer RM, Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc Natl Acad Sci USA. 86:1989;3375-3378.
6. Rees DD, Palmer RM, Hodson HF, Moncada S. A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation. Br J Pharmacol. 96:1989;418-424.
7. ω-nitro-L-arginine. Hypertension. 18:1991;683-688.
8. Pacicca C, von der Weid PY, Beny JL. Effect of nitro-L-arginine on endothelium-dependent hyperpolarizations and relaxations of pig coronary arteries. J Physiol (Lond). 457:1992;247-256.
9. Nagao T, Illiano S, Vanhoutte PM. Heterogeneous distribution of endothelium-dependent relaxations resistant to NG-nitro-L-arginine in rats. Am J Physiol. 263:1992;H1090-H1094.
10. Baydoun AR, Woodward B. Effects of bradykinin in the rat isolated perfused heart Role of kinin receptors and endothelium-derived relaxing factor . Br J Pharmacol. 103:1991;1829-1833.
11. Cowan CL, Cohen RA. Two mechanisms mediate relaxation by bradykinin of pig coronary artery NO-dependent and -independent responses . Am J Physiol. 261:1991;H830-H835.
12. +] A functional approach to separating EDHF- and EDNO-related mechanisms in perfused rat mesenteric arterial bed . J Cardiovasc Pharmacol. 21:1993;423-429.
13. Popp R, Bauersachs J, Fleming I, Busse R. Pulsatile stretch ensures the continuous release of EDHF in porcine coronary arteries. Pflugers Arch. 433:(suppl):1997;R29.
14. Buga GM, Gold ME, Fukuto JM, Ignarro LJ. Shear stress-induced release of nitric oxide from endothelial cells grown on beads. Hypertension. 17:1991;187-193.
15. Palmer RM, Rees DD, Ashton DS, Moncada S. L-Arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation. Biochem Biophys Res Commun. 153:1988;1251-1256.
16. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, Takayanagi T, Nagao T, Egashira K, Fujishima M, Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol. 28:1996;703-711.
17. Fulton D, McGiff JC, Quilley J. Contribution of NO and cytochrome P450 to the vasodilator effect of bradykinin in the rat kidney. Br J Pharmacol. 107:1992;722-725.
18. Fulton D, Mahboubi K, McGiff JC, Quilley J. Cytochrome P450-dependent effects of bradykinin in the rat heart. Br J Pharmacol. 114:1995;99-102.
19. Beny JL, Brunet PC, van der Bent V. Hemoglobin causes both endothelium-dependent and endothelium-independent contraction of the pig coronary arteries, independently of an inhibition of EDRF effects. Experientia. 45:1989;132-134.
20. Chen G, Suzuki H, Weston AH. Acetylcholine releases endothelium-derived hyperpolarizing factor and EDRF from rat blood vessels. Br J Pharmacol. 95:1988;1165-1174.
21. Komori K, Lorenz RR, Vanhoutte PM. Nitric oxide, ACh, and electrical and mechanical properties of canine arterial smooth muscle. Am J Physiol. 255:1988;H207-H212.
22. Huang AH, Busse R, Bassenge E. Endothelium-dependent hyperpolarization of smooth muscle cells in rabbit femoral arteries is not mediated by EDRF (nitric oxide). Naunyn Schmiedebergs Arch Pharmacol. 338:1988;438-442.
23. Nishiye E, Nakao K, Itoh T, Kuriyama H. Factors inducing endothelium-dependent relaxation in the guinea-pig basilar artery as estimated from the actions of haemoglobin. Br J Pharmacol. 96:1989;645-655.
24. Cocks TM, Angus JA. Evidence that contractions of isolated arteries by L-NMMA and NOLA are not due to inhibition of basal EDRF release. J Cardiovasc Pharmacol. 17:1991;S159-S164.
25. Komori K, Vanhoutte PM. Endothelium-derived hyperpolarizing factor. Blood Vessels. 27:1990;238-245.
26. Brayden JE. Membrane hyperpolarization is a mechanism of endothelium-dependent cerebral vasodilation. Am J Physiol. 259:1990;H668-H673.
27. Funaki S, Bohr DV. Electrical and mechanical activity of isolated vascular smooth muscle of the rat. Nature. 203:1964;192-194.
28. Kuriyama H, Suzuki H. The effects of acetylcholine on the membrane and contractile properties of smooth muscle cells of the rabbit superior mesenteric artery. Br J Pharmacol. 64:1978;493-501.
29. Bolton TB, Lang RJ, Takewaki T. Mechanism of action of noradrenaline and carbachol on smooth muscle of guinea-pig anterior mesenteric artery. J Physiol (Lond). 351:1984;549-572.
30. Chen G, Yamamoto Y, Miwa K, Suzuki H. Hyperpolarization of arterial smooth muscle induced by endothelial humoral substances. Am J Physiol. 260:1991;H1888-H1892.
31. Nagao T, Vanhoutte PM. Hyperpolarization contributes to endothelium-dependent relaxations to acetylcholine in femoral veins of rats. Am J Physiol. 261:1991;H1034-H1037.
32. Bolotina VM, Najibi S, Palacino JJ, Pagano PJ, Cohen RA. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-853.
33. Robertson BE, Schubert R, Hescheler J, Nelson MT. cGMP-dependent protein kinase activates Ca-activated K channels in cerebral artery smooth muscle cells. Am J Physiol. 265:1993;C299-C303.
34. + channel in cultured vascular smooth muscle cells. J Mol Cell Cardiol. 26:1994;1487-1495.
35. Beny JL, Brunet PC. Neither nitric oxide nor nitroglycerin accounts for all the characteristics of endothelially mediated vasodilatation of pig coronary arteries. Blood Vessels. 25:1988;308-311.
36. Brunet PC, Beny JL. Substance P and bradykinin hyperpolarize pig coronary artery endothelial cells in primary culture. Blood Vessels. 26:1989;228-234.
37. Nagao T, Vanhoutte PM. Hyperpolarization as a mechanism for endothelium-dependent relaxations in the porcine coronary artery. J Physiol (Lond). 445:1992;355-367.
38. Cohen RA, Vanhoutte PM. Endothelium-dependent hyperpolarization. Beyond nitric oxide and cyclic GMP. Circulation. 92:1995;3337-3349.
39. Mekata F. The role of hyperpolarization in the relaxation of smooth muscle of monkey coronary artery. J Physiol (Lond). 371:1986;257-265.
40. Parkington HC, Tonta MA, Coleman HA, Tare M. Role of membrane potential in endothelium-dependent relaxation of guinea-pig coronary arterial smooth muscle. J Physiol (Lond). 484:1995;469-480.
41. Gurney AM. Mechanisms of drug-induced vasodilation. J Pharm Pharmacol. 46:1994;242-251.
42. Nelson MT, Quayle JM. Physiological role and properties of potassium channels in arterial smooth muscle. Am J Physiol. 268:1995;C799-C822.
43. + channels in the vasodilator response to bradykinin in the rat heart. Br J Pharmacol. 113:1994;954-958.
44. Kilpatrick EV, Cocks TM. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery. Br J Pharmacol. 112:1994;557-565.
45. Kuhberger E, Kukovetz WR, Groschner K. Cromakalim inhibits multiple mechanisms of smooth muscle activation with similar stereoselectivity. J Cardiovasc Pharmacol. 21:1993;947-954.
46. Mustafa SJ, Askar AO. Effect of calcium entry blockers and adenosine on the relaxation of large and small coronary arteries. Life Sci. 38:1986;877-885.
47. Hintze TH, Vatner SF. Comparison of effects of nifedipine and nitroglycerin on large and small coronary arteries and cardiac function in conscious dogs. Circ Res. 52:1983;I139-I146.
48. + channels? Trends Pharmacol Sci. 14:1993;332-337.
49. Nakashima M, Mombouli JV, Taylor AA, Vanhoutte PM. Endothelium-dependent hyperpolarization caused by bradykinin in human coronary arteries. J Clin Invest. 92:1993;2867-2871.
50. Kitagawa S, Yamaguchi Y, Kunitomo M, Sameshima E, Fujiwara M. NG-nitro-L-arginine-resistant endothelium-dependent relaxation induced by acetylcholine in the rabbit renal artery. Life Sci. 55:1994;491-498.
51. Zygmunt PM, Waldeck K, Hogestatt ED. The endothelium mediates a nitric oxide-independent hyperpolarization and relaxation in the rat hepatic artery. Acta Physiol Scand. 152:1994;375-384.
52. Hecker M, Bara AT, Bauersachs J, Busse R. Characterization of endothelium-derived hyperpolarizing factor as a cytochrome P450-derived arachidonic acid metabolite in mammals. J Physiol (Lond). 481:1994;407-414.
53. Cowan CL, Cohen RA. Different mechanisms of relaxation of pig coronary artery to bradykinin and cromakalim are distinguished by potassium channel blockers. J Pharmacol Exp Ther. 260:1992;248-253.
54. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 78:1996;415-423.
55. Bauersachs J, Hecker M, Busse R. Display of the characteristics of endothelium-derived hyperpolarizing factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br J Pharmacol. 113:1994;1548-1553.
56. Garcia ML, Knaus HG, Munujos P, Slaughter RS, Kaczorowski GJ. Charybdotoxin and its effects on potassium channels. Am J Physiol. 269:1995;C1-C10.
57. + channels of human and rabbit erythrocytes display distinctive patterns of inhibition by venom peptide toxins. J Membr Biol. 147:1995;71-82.
58. Garcia-Calvo M, Leonard RJ, Novick J, Stevens SP, Schmalhofer W, Kaczorowski GJ, Garcia ML. Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels. J Biol Chem. 268:1993;18866-18874.
59. + channels . Br J Pharmacol. 118:1996;1504-1508.
60. Weintraub NL, Stephenson AH, Sprague RS, McMurdo L, Lonigro AJ. Relationship of arachidonic acid release to porcine coronary artery relaxation. Hypertension. 26:1995;684-690.
61. Marchenko SM, Sage SO. Mechanism of acetylcholine action on membrane potential of endothelium of intact rat aorta. Am J Physiol. 266:1994;H2388-H2395.
62. Cheung DW, Chen G. Calcium activation of hyperpolarized response to acetylcholine in coronary endothelial cells. J Cardiovasc Pharmacol. 20:(Suppl 12):1992;S120-S123.
63. Illiano S, Nagao T, Vanhoutte PM. Calmidazolium, a calmodulin inhibitor, inhibits endothelium-dependent relaxations resistant to nitro-L-arginine in the canine coronary artery. Br J Pharmacol. 107:1992;387-392.
64. Nagao T, Illiano S, Vanhoutte PM. Calmodulin antagonists inhibit endothelium-dependent hyperpolarization in the canine coronary artery. Br J Pharmacol. 107:1992;382-386.
65. 2+ influx and formation of EDRF in vascular endothelial cells. Jpn J Pharmacol. 58:(Suppl 2):1992;213P-219P.
66. Takeda K, Klepper M. Voltage-dependent and agonist-activated ionic currents in vascular endothelial cells A review . Blood Vessels. 27:1990;169-183.
67. Adams DJ, Barakeh J, Laskey R, van Breemen C. Ion channels and regulation of intracellular calcium in vascular endothelial cells. FASEB J. 3:1989;2389-2400.
68. 2+ and nitric oxide in bradykinin-stimulated vascular endothelial cells. Circ Res. 76:1995;922-924.
69. Frieden M, Beny JL. Effect of 5-hydroxytryptamine on the membrane potential of endothelial and smooth muscle cells in the pig coronary artery. Br J Pharmacol. 115:1995;95-100.
70. 2+ ionophores on membrane potential of pig coronary artery endothelial cells. Am J Physiol. 262:1992;H1823-H1831.
71. Chen G, Cheung DW. Characterization of acetylcholine-induced membrane hyperpolarization in endothelial cells. Circ Res. 70:1992;257-263.
72. Beny JL, Gribi F. Dye and electrical coupling of endothelial cells in situ. Tissue Cell. 21:1989;797-802.
73. Beny JL, Connat JL. An electron-microscopic study of smooth muscle cell dye coupling in the pig coronary arteries. Role of gap junctions. Circ Res. 70:1992;49-55.
74. Beny JL, Pacicca C. Bidirectional electrical communication between smooth muscle and endothelial cells in the pig coronary artery. Am J Physiol. 266:1994;H1465-H1472.
75. Little TL, Xia J, Duling BR. Dye tracers define differential endothelial and smooth muscle coupling patterns within the arteriolar wall. Circ Res. 76:1995;498-504.
76. Nelson MT, Cheng H, Rubart M, Santana LF, Bonev D, Knot HJ, Lederer WJ. Relaxation of arterial smooth muscle by calcium sparks. Science. 270:1995;633-637.
77. Kuhberger E, Groschner K, Kukovetz WR, Brunner F. The role of myoendothelial cell contact in non-nitric oxide-, non-prostanoid-mediated endothelium-dependent relaxation of porcine coronary artery. Br J Pharmacol. 113:1994;1289-1294.
78. Beny JL. Endothelial and smooth muscle cells hyperpolarized by bradykinin are not dye coupled. Am J Physiol. 258:1990;H836-H841.
79. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol. 93:1988;515-524.
80. + conductance . Circ Res. 65:1989;199-204.
81. Taylor SG, Weston AH. Endothelium-derived hyperpolarizing factor A new endogenous inhibitor from the vascular endothelium . Trends Pharmacol Sci. 9:1988;272-274.
82. Moncada S, Palmer RM, Gryglewski RJ. Mechanism of action of some inhibitors of endothelium-derived relaxing factor. Proc Natl Acad Sci USA. 83:1986;9164-9168.
83. Mombouli JV, Bissiriou I, Agboton VD, Vanhoutte PM. Bioassay of endothelium-derived hyperpolarizing factor. Biochem Biophys Res Commun. 221:1996;484-488.
84. Harder DR, Campbell WB, Pratt PF, Jacobs ER, Gebremedhin D. Bioassay of endothelium derived cytochrome P450-dependent hyperpolarizing factor from bovine coronary arteries. FASEB J. 10:1996;A301.
85. Parkington HC, Tare M, Tonta MA, Coleman HA. Stretch revealed three components in the hyperpolarization of guinea-pig coronary artery in response to acetylcholine. J Physiol (Lond). 465:1993;459-476.
86. Beny JL, von der Weid PY. Hydrogen peroxide An endogenous smooth muscle cell hyperpolarizing factor . Biochem Biophys Res Commun. 176:1991;378-384.
87. Vanhoutte PM. Vascular physiology The end of the quest? Nature. 327:1987;459-460.
88. Singer HA, Saye JA, Peach MJ. Effects of cytochrome P-450 inhibitors on endothelium-dependent relaxation in rabbit aorta. Blood Vessels. 21:1984;223-230.
89. Marletta MA. Nitric oxide synthase Aspects concerning structure and catalysis . Cell. 78:1994;927-930.
90. Abraham NG, Pinto A, Mullane KM, Levere RD, Spokas E. Presence of cytochrome P-450-dependent monooxygenase in intimal cells of the hog aorta. Hypertension. 7:1985;899-904.
91. Rosolowsky M, Falck JR, Campbell WB. Synthesis and biological activity of epoxyeicosatrienoic acids (EETs) by cultured bovine coronary artery endothelial cells. Adv Prostaglandin Thromboxane Leukot Res. 21A:1991;213-216.
92. Rosolowsky M, Campbell WB. Synthesis of hydroxyeicosatetraenoic (HETEs) and epoxyeicosatrienoic acid (EETs) by cultured bovine coronary artery endothelial cells. Biochim Biophys Acta. 1299:1996;267-277.
93. Pfister SL, Falck JR, Campbell WB. Enhanced synthesis of epoxyeicosatrienoic acids by cholesterol-fed rabbit aorta. Am J Physiol. 261:1991;H843-H852.
94. Proctor KG, Falck JR, Capdevila J. Intestinal vasodilation by epoxyeicosatrienoic acids Arachidonic acid metabolites produced by a cytochrome P450 monooxygenase . Circ Res. 60:1987;50-59.
95. Carroll MA, Garcia MP, Falck JR, McGiff JC. 5,6-Epoxyeicosatrienoic acid, a novel arachidonate metabolite. Mechanism of vasoactivity in the rat. Circ Res. 67:1990;1082-1088.
96. Gebremedhin D, Ma YH, Falck JR, Roman RJ, VanRollins M, Harder DR. Mechanism of action of cerebral epoxyeicosatrienoic acids on cerebral arterial smooth muscle. Am J Physiol. 263:1992;H519-H525.
97. + channel activity in renal arterioles. Hypertension. 24:1994;382.
98. 2 and epoxyeicosatrienoic acids in relaxation of bovine coronary arteries to arachidonic acid. Am J Physiol. 264:1993;H327-H335.
99. Rosolowsky M, Falck JR, Willerson JT, Campbell WB. Synthesis of lipoxygenase and epoxygenase products of arachidonic acid by normal and stenosed canine coronary arteries. Circ Res. 66:1990;608-621.
100. Carroll MA, Balazy M, Margiotta P, Falck JR, McGiff JC. Renal vasodilator activity of 5,6-epoxyeicosatrienoic acid depends upon conversion by cyclooxygenase and release of prostaglandins. J Biol Chem. 268:1993;12260-12266.
101. Fulton D, Balazy M, McGiff JC, Quilley J. Possible contribution of platelet cyclooxygenase to the renal vascular action of 5,6-epoxyeicosatrienoic acid. J Pharmacol Exp Ther. 277:1996;1195-1199.
102. + channel in vascular smooth muscles by cytochrome P450 metabolites of arachidonic acid. Eur J Pharmacol. 230:1993;215-221.
103. 2 in the nitric oxide-independent vasodilator effect of bradykinin in the rat perfused heart. J Pharmacol Exp Ther. 278:1996;518-526.
104. 2 and vasorelaxation by lysophosphatidylcholine. Life Sci. 47:1990;1941-1948.
105. Harder DR, Campbell WB, Roman RJ. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J Vasc Res. 32:1995;79-92.
106. Choo LK, Malta E, Mitchelson F. Investigation of the antimuscarinic and other actions of proadifen in-vitro. J Pharm Pharmacol. 38:1986;898-901.
107. Pinto A, Abraham NG, Mullane KM. Arachidonic acid-induced endothelial-dependent relaxations of canine coronary arteries Contribution of a cytochrome P-450-dependent pathway . J Pharmacol Exp Ther. 240:1987;856-863.
108. Xie JM, Wang Y, Greenberg SS. SKF-525A does not inhibit release of endothelium-derived relaxing factor from rat thoracic aorta and dog mesenteric and femoral artery. Blood Vessels. 28:1991;475-489.
109. Bennett BM, McDonald BJ, Nigam R, Long PG, Simon WC. Inhibition of nitrovasodilator- and acetylcholine-induced relaxation and cyclic GMP accumulation by the cytochrome P-450 substrate, 7-ethoxyresorufin. Can J Physiol Pharmacol. 70:1992;1297-1303.
110. + transport and cell dehydration in sickle erythrocytes by clotrimazole and other imidazole derivatives. J Clin Invest. 92:1993;520-526.
111. + channel The imidazole ring is not required for inhibitory activity . J Pharmacol Exp Ther. 273:1995;266-272.
112. Dudek RR, Conforto A, Pinto V, Wildhirt S, Suzuki H. Inhibition of endothelial nitric oxide synthase by cytochrome P-450 reductase inhibitors. Proc Soc Exp Biol Med. 209:1995;60-64.
113. Wolff DJ, Datto GA, Samatovicz RA, Tempsick RA. Calmodulin-dependent nitric-oxide synthase. Mechanism of inhibition by imidazole and phenylimidazoles. J Biol Chem. 268:1993;9425-9429.
114. Weintraub NL, Joshi SN, Branch CA, Stephenson AH, Sprague RS, Lonigro AJ. Relaxation of porcine coronary artery to bradykinin. Role of arachidonic acid. Hypertension. 23:1994;976-981.
115. Capdevila JH, Kishore V, Dishman E, Blair IA, Falck JR. A novel pool of rat liver inositol and ethanolamine phospholipids contains epoxyeicosatrienoic acids (EETs). Biochem Biophys Res Commun. 146:1987;638-644.
116. Zhu Y, Schieber EB, McGiff JC, Balazy M. Identification of arachidonate P-450 metabolites in human platelet phospholipids. Hypertension. 25:1995;854-859.
117. Takahashi K, Capdevila J, Karara A, Falck JR, Jacobson HR, Badr KF. Cytochrome P-450 arachidonate metabolites in rat kidney Characterization and hemodynamic responses . Am J Physiol. 258:1990;F781-F789.
118. 2+ entry in human and bovine endothelial cells. J Physiol (Lond). 482:1995;259-274.
119. Bondy SC, Naderi S. Contribution of hepatic cytochrome P450 systems to the generation of reactive oxygen species. Biochem Pharmacol. 48:1994;155-159.
120. + channels by hydrogen peroxide. Biochem Biophys Res Commun. 186:1992;1681-1687.
121. Fulton D, McGiff JC, Kaminski P, Wolin MS, Quilley J. Evidence against a P450-derived free radical as the mediator of the NO-independent vasodilator effect of bradykinin in the rat perfused heart. J Pharmacol Exp Ther. 280:1997;702-709.
122. Khatsenko OG, Gross SS, Rifkind AB, Vane JR. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci USA. 90:1993;11147-11151.
123. Makita K, Takahashi K, Karara A, Jacobson HR, Falck JR, Capdevila JH. Experimental and/or genetically controlled alterations of the renal microsomal cytochrome P450 epoxygenase induce hypertension in rats fed a high salt diet. J Clin Invest. 94:1994;2414-2420.
124. Brayden JE, Nelson MT. Regulation of arterial tone by activation of calcium-dependent potassium channels. Science. 256:1992;532-535.
125. Nagao T, Vanhoutte PM. Endothelium-derived hyperpolarizing factor and endothelium-dependent relaxations. Am J Respir Cell Mol Biol. 8:1993;1-6.
126. Guzelian PS, Bissell DM, Meyer UA. Drug metabolism in adult rat hepatocytes in primary monolayer culture. Gastroenterology. 72:1977;1232-1239.
127. Quilley J, Sarubbi D, McGiff JC. Influence of diabetes mellitus on renal vascular responses to bradykinin. Agents Actions. 38:1992;31-35.
128. Tesfamariam B. Selective impairment of endothelium-dependent relaxations by prostaglandin endoperoxide. J Hypertens. 12:1994;41-47.
129. + channels regulate the myogenic tone in the resting state of arteries from spontaneously hypertensive rats. Br J Pharmacol. 108:1993;214-222.
130. Watts SW, Finta KM, Lloyd MC, Storm DS, Webb RC. Enhanced vascular responsiveness to Bay K 8644 in mineralocorticoid- and N-nitro arginine-induced hypertension. Blood Press. 3:1994;340-348.
131. Mayhan WG. Effect of diabetes mellitus on response of the basilar artery to activation of ATP-sensitive potassium channels. Brain Res. 636:1994;35-39.
132. Quilley J, McGiff JC, Mieyal P, Rapacon M, Fulton D. NO-independent coronary vasodilation to bradykinin in diabetes. Hypertension. 28:1996;552.
133. Fulton D, McGiff JC, Quilley J. Cytochrome P450 arachidonate metabolites (P450-AA) Deficit in diabetes mellitus . FASEB J. 9:1996;A113.
134. Cameron NE, Cotter MA. Impaired contraction and relaxation in aorta from streptozotocin-diabetic rats Role of polyol pathway . Diabetologia. 35:1992;1011-1019.